Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sibo Yang

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Hepatocellular Carcinoma|March 9, 2023
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular CarcinomaJin Lei, Sibo Yang, Bowen Chen, et al.
Clinical Drug Investigation|June 16, 2023
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese VolunteersJunyu Xu, Nan Zhao, Jie Huang, et al.
Cell Death & Disease|May 14, 2022
Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transitionYan Luo, Hang Yang, Yan Wan, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 12, 2025
Real-Time Monitoring of Atherosclerotic Plaque Using β-Galactosidase-Activated Photoacoustic TomographyYifan Zhou, Hang Yang, Handi Deng, et al.
Advanced Healthcare Materials|May 24, 2021
pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic StrokeHang Yang, Yan Luo, Hang Hu, et al.
Brain and Behavior|December 6, 2023
Association of white matter hyperintensities with long-term EGFR-TKI treatment and prediction of progression riskHang Yang, Rui Meng, Junjie Jiang, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Hepatocellular Carcinoma|March 9, 2023
Efficacy and Safety of Tyrosine Kinase Inhibitors Alone or Combination with Programmed Death-1 Inhibitors in Treating of Hepatitis C-Related Hepatocellular CarcinomaJin Lei, Sibo Yang, Bowen Chen, et al.
Clinical Drug Investigation|June 16, 2023
The Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, an Oral Small Molecule Factor XIa Inhibitor, in Healthy Chinese VolunteersJunyu Xu, Nan Zhao, Jie Huang, et al.
Cell Death & Disease|May 14, 2022
Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transitionYan Luo, Hang Yang, Yan Wan, et al.
Diabetes, Obesity & Metabolism|April 20, 2026
A Phase 1, Randomised, Double-Blind, Placebo-Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP-1R Agonist and GIPR Antagonist) in Male Adults With Overweight or ObesityJinlian Xie, Jie Huang, Qian Wu, et al.
Small (Weinheim an Der Bergstrasse, Germany)|September 12, 2025
Real-Time Monitoring of Atherosclerotic Plaque Using β-Galactosidase-Activated Photoacoustic TomographyYifan Zhou, Hang Yang, Handi Deng, et al.
Advanced Healthcare Materials|May 24, 2021
pH-Sensitive, Cerebral Vasculature-Targeting Hydroxyethyl Starch Functionalized Nanoparticles for Improved Angiogenesis and Neurological Function Recovery in Ischemic StrokeHang Yang, Yan Luo, Hang Hu, et al.
Brain and Behavior|December 6, 2023
Association of white matter hyperintensities with long-term EGFR-TKI treatment and prediction of progression riskHang Yang, Rui Meng, Junjie Jiang, et al.
Pageof 3